Clinical Trial Update: Study of Phenobarbital Inhibition of Catamenial Epilepsy [NA]

View source ↗

Summary

The study evaluating phenobarbital for catamenial epilepsy has been withdrawn from clinical trials, with no current recruitment or results anticipated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Phenobarbital (phenobarbital)

Snippet

Sponsor: University of Toledo Health Science Campus | Conditions: Epilepsy | NA | Status: WITHDRAWN